Wegovy pill now on sale in UK pharmacies: what you need to know
The Wegovy pill is now available to buy privately from UK high street and online pharmacies, offering a daily oral alternative to Wegovy injections. It contains semaglutide and is MHRA-approved for adults with obesity or overweight with related conditions—but it is not yet available on the NHS. Pharmacies are bracing for heavy demand as the first GLP-1 weight-loss tablet goes on sale.
Key Takeaways
- The Wegovy pill launched privately in UK pharmacies in early July 2026, with starting doses from about £79–£99 per month.
- It uses the same active ingredient as Wegovy injections and requires a clinical consultation before purchase.
- NHS access is not confirmed; experts say NICE appraisal could take until 2027 or 2028.
- Strict dosing rules apply: take on an empty stomach with plain water after at least eight hours without food.
- Trial data showed average weight loss of about 13.6% over 64 weeks alongside diet and exercise.
The once-a-day wegovy pill marks a major shift in how weight-loss medication reaches British patients. For more on how medical tech is reshaping everyday care, see our Future Tech & AI Wonders coverage.
What is the Wegovy pill and who can get it?
The tablet contains semaglutide, the same ingredient used in Wegovy injections. It mimics the hormone GLP-1 to reduce appetite and is meant to be used alongside a reduced-calorie diet and increased physical activity—not as a cosmetic quick fix.
Private pharmacies can supply it to adults with a BMI of 30 or above, or a BMI of 27–30 with weight-related conditions such as type 2 diabetes or high blood pressure. That mirrors eligibility for the injectable version.
Before you receive it, a prescriber must confirm it is appropriate through an online or face-to-face consultation. The BBC reports that many pharmacies are already fielding strong interest, with some offering waiting lists.
How much does the Wegovy pill cost privately?
Prices vary by pharmacy and dose. Superdrug Online Doctor is offering the 1.5mg starting dose at £79 per month for new patients and £99 for existing patients, according to The i Paper. Step-up doses cost more, with higher strengths reaching up to around £229 monthly.
Other outlets quote similar ranges. Some list 1.5mg at £99 and the maximum 25mg dose at about £199 for a 30-day supply. Simple Online Pharmacy told reporters it had already approved pre-orders from roughly 10,000 customers ahead of dispatch.
Costs are broadly in line with private injection prices for now. Experts hope tablet manufacturing could eventually bring prices down, but that is not guaranteed.
How do you take the Wegovy pill correctly?
Dosing starts at 1.5mg once daily for one month, then typically increases each month after review until the maximum recommended dose of 25mg daily. Patients on private 2.4mg injections may switch to 25mg tablets under medical supervision.
Absorption rules are strict. Take the pill on an empty stomach after fasting for at least eight hours, at least 30 minutes before eating, drinking anything other than water, or taking other medicines. Swallow it whole with up to 120ml of plain water at the same time each day.
Common side effects include nausea, vomiting, constipation, and diarrhoea. More serious complications are rare but possible. It is not suitable for under-18s, pregnant or breastfeeding women, or anyone without a proper clinical assessment.
When will the Wegovy pill be available on the NHS?
The MHRA approved the tablet in June 2026—the first oral GLP-1 treatment cleared for weight management in the UK. Approval does not mean NHS prescribing is imminent.
NICE must still assess cost-effectiveness before the health service can offer it routinely. Pharmacy leaders and clinicians quoted by The i Paper suggest NHS access may not arrive until 2027 or 2028, though some hope the timeline could be shorter.
That gap has fuelled warnings of a two-tier system: those who can afford private monthly fees may benefit sooner, while lower-income patients wait. With more than 1.5 million Britons already using weight-loss injections privately or via limited NHS routes, demand for the pill is expected to be substantial.